ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
0.5396
+0.0167 (3.19%)
At close: May 20, 2025, 4:00 PM
0.5362
-0.0034 (-0.63%)
Pre-market: May 21, 2025, 8:09 AM EDT
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $1.95 million as of May 21, 2025. Its market cap has decreased by -52.82% in one year.
Market Cap
1.95M
Enterprise Value
341.53K
1-Year Change
-52.82%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from $95.47M to $1.95M, a decrease of -97.95%. That is a compound annual growth rate of -69.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 1.95M | -21.40% |
| Dec 31, 2024 | 2.48M | -47.34% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |